Skip To Main Content

Global X Equal Weight Global Healthcare Index ETF

MEDX

Reasons to Consider MEDX

Exposure to Leading Healthcare Companies

MEDX provides equal-weighted exposure to the 20 largest global healthcare companies listed on major developed market exchanges. This approach helps ensure balanced exposure across industry leaders, capturing comprehensive global growth potential.

Growth Driven by Long-Term Healthcare Trends

Global healthcare spending is projected to grow at a compounded annual rate of 7.3%, reaching approximately $12 trillion by 2030. MEDX is positioned to benefit from these persistent trends, offering investors access to companies at the forefront of healthcare advancement. ¹
¹ World Economic Forum, 2023

Resilience and Diversification

Healthcare companies typically exhibit resilience due to consistent demand for medical products and services, even during economic downturns.²
² CBRE, 2023

Investment Objective

MEDX seeks to replicate, to the extent reasonably possible and net of expenses, the performance of an equal-weighted index designed to provide exposure to the largest healthcare companies globally (currently, the VettaFi Equal Weight Global Healthcare Index).

NAV

$19.60

$0.3694

1.92%

Volume

54

Price

$19.70

$-0.40

-1.99%

Last Close

$20.10

Prices delayed by 15 minutes.

Last Trade: May 16, 2025
Equity
Sector
World
Sectors
Thematic

Risk Rating:

Medium

Product Details

Fund Details

Ticker

MEDX

CUSIP

379941107

Inception Date

April 30, 2025

Net Assets

$1,959,939 As at May 15, 2025

Average Daily Trading Volume Over a 12 Month Period

2,642

Exchange

Toronto Stock Exchange

Investment Manager

Global X Investments Canada Inc.

Eligibility

All Registered and Non-Registered Investment Accounts

Bloomberg Index Ticker

VMEDXCN

Management Fee

0.40% (Plus applicable sales tax)

Management Expense Ratio

N/A (New ETF)

Trading Expense Ratio

N/A (New ETF)

Currency

CAD

Currency Hedging

N/A

LEI

894500NI2JGX2C7QEU04

Distribution Metrics

Distribution Frequency

Quarterly

Price and NAV

As at May 15, 2025

NAV / Unit

$19.60

Closing Price

$19.70

Premium Discount

$0.10

Premium Discount Percentage

0.51%

Outstanding Shares

100,001

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

Annualized Performance (%)

Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.

Calendar Year Performance (%)

Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.

Top Holdings

As at May 15, 2025

Security Name

Weight

Intuitive Surgical Inc

6.07%

Boston Scientific Corp

5.94%

Stryker Corp

5.81%

Abbott Laboratories

5.47%

Novartis AG

5.30%

Danaher Corp

5.06%

Johnson & Johnson

5.04%

Vertex Pharmaceuticals Inc

4.98%

Roche Holding AG - Partcptn

4.96%

AstraZeneca PLC - ADR

4.93%

Holdings are subject to change.

Commissions, management fees, and expenses all may be associated with an investment in products (the "Global X Funds") managed by Global X Investments Canada Inc. The Global X Funds are not guaranteed, their values change frequently and past performance may not be repeated. Certain Global X Funds may have exposure to leveraged investment techniques that magnify gains and losses which may result in greater volatility in value and could be subject to aggressive investment risk and price volatility risk. Such risks are described in the prospectus. The Global X Money Market Funds are not covered by the Canada Deposit Insurance Corporation, the Federal Deposit Insurance Corporation, or any other government deposit insurer. There can be no assurances that the money market fund will be able to maintain its net asset value per security at a constant amount or that the full amount of your investment in the Funds will be returned to you. Past performance may not be repeated. The prospectus contains important detailed information about the Global X Funds. Please read the relevant prospectus before investing.

Global X Investments Canada Inc. ("Global X") is a wholly-owned subsidiary of Mirae Asset Global Investments Co., Ltd. ("Mirae Asset"), the Korea-based asset management entity of Mirae Asset Financial Group. Global X is a corporation existing under the laws of Canada and is the manager, investment manager and trustee of the Global X Funds.

© 2025 Global X Investments Canada Inc. All Rights Reserved.